Sodium 3-(10H-phenothiazin-10-yl)propane-1-sulfonate, 95.0%, 1g

Methyl 5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylate hydrochloride, 97%, 5g

4-tert-Butylaniline>98.0%(GC)(T)25mL

4-Hydroxy-L-(+)-2-phenylglycine>99.0%(HPLC)(T)25g

ethyl 3-amino-1-methyl-1H-pyrazole-5-carboxylate, 95%, 250mg

(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)methanamine, 97%, 100mg

(2-Oxo-2,3-dihydrobenzo[d]oxazol-6-yl)boronic acid, 95.0%, 1g

3-(Diphenylamino)dibenzo[g,p]chrysene>97.0%(HPLC)200mg

(S)-tert-Butyl 6-methyl-6,7-dihydropyrazolo[1,5-a]pyrazine-5(4H)-carboxylate, 97%, 250mg

(S)-ethyl 2-amino-3,3-dimethylbutanoate hydrochloride, 98%, 1g

GC capillary column ROTI®Cap-5, 60 m, 0.32 mm, 0.50 µm, 1 Piece(s)

Ethyl O-Mesitylsulfonylacetohydroxamate [Precursor of the Powerful Aminating Reagent]>98.0%(HPLC)(N)25g

Xanthine monosodium salt, monohydrate, 96.0%, 1g